A chemist for the Food and Drug Administration and his son are accused of reaping $2.27 million in illegal profits from an insider-trading scheme that allegedly used information from a password-protected FDA site concerning pending drug applications. Cheng Yi Liang, 57, and his son, Andrew, 25, face criminal conspiracy charges…
Mar 29, 2011 10:23 PM CDT